KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Tax Provisions (2016 - 2025)

Biogen (BIIB) has 16 years of Tax Provisions data on record, last reported at -$7.1 million in Q4 2025.

  • For Q4 2025, Tax Provisions fell 128.63% year-over-year to -$7.1 million; the TTM value through Dec 2025 reached $263.6 million, down 3.73%, while the annual FY2025 figure was $263.6 million, 3.73% down from the prior year.
  • Tax Provisions reached -$7.1 million in Q4 2025 per BIIB's latest filing, down from $90.8 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $443.3 million in Q4 2021 and bottomed at -$409.1 million in Q2 2021.
  • Average Tax Provisions over 4 years is $76.4 million, with a median of $71.0 million recorded in 2024.
  • The widest YoY moves for Tax Provisions: up 3208.21% in 2021, down 191.71% in 2021.
  • A 4-year view of Tax Provisions shows it stood at $443.3 million in 2021, then tumbled by 87.75% to $54.3 million in 2022, then crashed by 54.33% to $24.8 million in 2024, then plummeted by 128.63% to -$7.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were -$7.1 million in Q4 2025, $90.8 million in Q3 2025, and $109.2 million in Q2 2025.